187 related articles for article (PubMed ID: 24476768)
1. The germline sequence variant rs2736100_C in TERT associates with myeloproliferative neoplasms.
Oddsson A; Kristinsson SY; Helgason H; Gudbjartsson DF; Masson G; Sigurdsson A; Jonasdottir A; Jonasdottir A; Steingrimsdottir H; Vidarsson B; Reykdal S; Eyjolfsson GI; Olafsson I; Onundarson PT; Runarsson G; Sigurdardottir O; Kong A; Rafnar T; Sulem P; Thorsteinsdottir U; Stefansson K
Leukemia; 2014 Jun; 28(6):1371-4. PubMed ID: 24476768
[No Abstract] [Full Text] [Related]
2. Common germline variation at the TERT locus contributes to familial clustering of myeloproliferative neoplasms.
Jäger R; Harutyunyan AS; Rumi E; Pietra D; Berg T; Olcaydu D; Houlston RS; Cazzola M; Kralovics R
Am J Hematol; 2014 Dec; 89(12):1107-10. PubMed ID: 25196853
[TBL] [Abstract][Full Text] [Related]
3. TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms - a multicentric study on 529 patients.
Trifa AP; Bănescu C; Tevet M; Bojan A; Dima D; Urian L; Török-Vistai T; Popov VM; Zdrenghea M; Petrov L; Vasilache A; Murat M; Georgescu D; Popescu M; Pătrinoiu O; Balea M; Costache R; Coleș E; Șaguna C; Berbec N; Vlădăreanu AM; Mihăilă RG; Bumbea H; Cucuianu A; Popp RA
Br J Haematol; 2016 Jul; 174(2):218-26. PubMed ID: 27061303
[TBL] [Abstract][Full Text] [Related]
4. The
Hong T; Luo M; Liu Q
Genet Test Mol Biomarkers; 2020 Apr; 24(4):181-187. PubMed ID: 32202925
[No Abstract] [Full Text] [Related]
5. TERT and JAK2 polymorphisms define genetic predisposition to myeloproliferative neoplasms in Japanese patients.
Matsuguma M; Yujiri T; Yamamoto K; Kajimura Y; Tokunaga Y; Tanaka M; Tanaka Y; Nakamura Y; Tanizawa Y
Int J Hematol; 2019 Dec; 110(6):690-698. PubMed ID: 31571131
[TBL] [Abstract][Full Text] [Related]
6. Co-occurrence of Myeloproliferative Neoplasms and Solid Tumors Is Attributed to a Synergism Between Cytoreductive Therapy and the Common TERT Polymorphism rs2736100.
Krahling T; Balassa K; Kiss KP; Bors A; Batai A; Halm G; Egyed M; Fekete S; Remenyi P; Masszi T; Tordai A; Andrikovics H
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):98-104. PubMed ID: 26487696
[TBL] [Abstract][Full Text] [Related]
7. TERT rs2736100 genotypes are associated with differential risk of myeloproliferative neoplasms in Swedish and Chinese male patient populations.
Dahlström J; Liu T; Yuan X; Saft L; Ghaderi M; Wei YB; Lavebratt C; Li P; Zheng C; Björkholm M; Xu D
Ann Hematol; 2016 Oct; 95(11):1825-32. PubMed ID: 27561898
[TBL] [Abstract][Full Text] [Related]
8. Rare germline variant contributions to myeloid malignancy susceptibility.
Li ST; Wang J; Wei R; Shi R; Adema V; Nagata Y; Kerr CM; Kuzmanovic T; Przychodzen B; Sole F; Maciejewski JP; LaFramboise T
Leukemia; 2020 Jun; 34(6):1675-1678. PubMed ID: 31911633
[No Abstract] [Full Text] [Related]
9. The TERT promoter mutation incidence is modified by germline TERT rs2736098 and rs2736100 polymorphisms in hepatocellular carcinoma.
Yuan X; Cheng G; Yu J; Zheng S; Sun C; Sun Q; Li K; Lin Z; Liu T; Li P; Xu Y; Kong F; Bjorkholm M; Xu D
Oncotarget; 2017 Apr; 8(14):23120-23129. PubMed ID: 28416747
[TBL] [Abstract][Full Text] [Related]
10. An analysis of the
Palmer D; Nacheva E
Leuk Lymphoma; 2021 May; 62(5):1255-1258. PubMed ID: 33349109
[No Abstract] [Full Text] [Related]
11. Inherited predisposition to myeloid malignancies.
Godley LA
Blood Adv; 2019 Sep; 3(17):2688. PubMed ID: 31506287
[No Abstract] [Full Text] [Related]
12. A new family with a germline ANKRD26 mutation and predisposition to myeloid malignancies.
Marquez R; Hantel A; Lorenz R; Neistadt B; Wong J; Churpek JE; Mardini NA; Shaukat I; Gurbuxani S; Miller JL; Godley LA
Leuk Lymphoma; 2014 Dec; 55(12):2945-6. PubMed ID: 24628296
[No Abstract] [Full Text] [Related]
13. The TERT rs2736100 polymorphism increases cancer risk: A meta-analysis.
Li H; Xu Y; Mei H; Peng L; Li X; Tang J
Oncotarget; 2017 Jun; 8(24):38693-38705. PubMed ID: 28418878
[TBL] [Abstract][Full Text] [Related]
14. Somatic mutations in calreticulin can be found in pedigrees with familial predisposition to myeloproliferative neoplasms.
Lundberg P; Nienhold R; Ambrosetti A; Cervantes F; Pérez-Encinas MM; Skoda RC
Blood; 2014 Apr; 123(17):2744-5. PubMed ID: 24764562
[No Abstract] [Full Text] [Related]
15. [Myeloid neoplasms with germline predisposition].
Yoshida K
Rinsho Ketsueki; 2023; 64(9):949-954. PubMed ID: 37793870
[TBL] [Abstract][Full Text] [Related]
16. Germline genetic factors in the pathogenesis of myeloproliferative neoplasms.
Bellanné-Chantelot C; Rabadan Moraes G; Schmaltz-Panneau B; Marty C; Vainchenker W; Plo I
Blood Rev; 2020 Jul; 42():100710. PubMed ID: 32532454
[TBL] [Abstract][Full Text] [Related]
17. Germline transmission of LNKE208Q variant in a family with myeloproliferative neoplasms.
Loscocco GG; Mannarelli C; Pacilli A; Fanelli T; Rotunno G; Gesullo F; Corbizi-Fattori G; Vannucchi AM; Guglielmelli P
Am J Hematol; 2016 Sep; 91(9):E356. PubMed ID: 27237057
[No Abstract] [Full Text] [Related]
18. Myeloid neoplasms with germline predisposition: Practical considerations and complications in the search for new susceptibility loci.
Carraway HE; LaFramboise T
Best Pract Res Clin Haematol; 2020 Sep; 33(3):101191. PubMed ID: 33038980
[TBL] [Abstract][Full Text] [Related]
19. The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms.
Olcaydu D; Rumi E; Harutyunyan A; Passamonti F; Pietra D; Pascutto C; Berg T; Jäger R; Hammond E; Cazzola M; Kralovics R
Haematologica; 2011 Mar; 96(3):367-74. PubMed ID: 21173100
[TBL] [Abstract][Full Text] [Related]
20. Activating somatic and germline TERT promoter variants in myeloid malignancies.
Nofrini V; Matteucci C; Pellanera F; Gorello P; Di Giacomo D; Lema Fernandez AG; Nardelli C; Iannotti T; Brandimarte L; Arniani S; Moretti M; Gili A; Roti G; Di Battista V; Colla S; Mecucci C
Leukemia; 2021 Jan; 35(1):274-278. PubMed ID: 32366939
[No Abstract] [Full Text] [Related]
[Next] [New Search]
